Table 1.
Characteristics of the study population
All (n = 676) | LI+ (n = 64) | LI− (n = 612) | p value | |
---|---|---|---|---|
AST | 48 (31–106) | 276 (48–503) | 44 (16–73) | <0.001 |
ALT | 36 (22–69) | 240 (92–388) | 32 (16–49) | <0.001 |
ISS | 17 (9–26) | 21 (9–33) | 17 (9–26) | <0.01 |
GCS | 15 (13–15) | 15 (14–15) | 14 (13–15) | 0.67 |
RTS | 7.84 (6.90–7.84) | 7.84 (7.37–7.84) | 7.84 (7.37–7.84) | 0.32 |
Ps | 97.0 (89.5–99.2) | 95.7 (88.1–100) | 97.4 (92.9–100) | 0.19 |
Age | 46 (29–63) | 40 (23–57) | 46 (29–63) | 0.17 |
Male gender, n (%) | 462 (68.3) | 36 (56.3) | 426 (69.6) | 0.03 |
Mortality, n (%) | 58 (8.6) | 5 (7.8) | 53 (8.7) | 0.82 |
Values are given as median (IQR) where not stated otherwise
LI+ with liver injury, LI− without liver injury, AST aspartate aminotransferase, ALT alanine aminotransferase, ISS injury severity score, GCS Glasgow coma scale, RTS revised trauma score, Ps probability of survival